Question 1

What is Syndax Pharmaceuticals?

Accepted Answer

Syndax Pharmaceuticals is a Company.

Question 2

How often does Syndax Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Syndax Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Apr 07, 2026.

Question 4

When was Syndax Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is Syndax Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Syndax Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Syndax Pharmaceuticals?

Accepted Answer

Syndax Revuforj Data at EHA 2026 (May 12, 2026, 7 articles).

Question 8

How did the "Syndax Revuforj Data at EHA 2026" event impact Syndax Pharmaceuticals?

Accepted Answer

Syndax Pharmaceuticals highlighted positive clinical data for its drug Revumenib (revumenib) at the European Hematology Association (EHA) 2026 Congress, reinforcing its leadership in menin inhibition and potentially transforming acute leukemia treatment.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.